Evaluating the Pharmacokinetic Interactions and Safety Between AD-2111 and AD-2112

NCT04375865 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: AD-2111
DRUG: AD-2112

Sponsor

Addpharma Inc.